How to Buy Immunocore Holdings Stock
Immunocore Holdings PLC
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.
Immunocore Holdings stock last closed at $29.41, up 3.52% from the previous day, and has decreased 47.31% in one year. It has overperformed other stocks in the Biotechnology industry by 0.3 percentage points. Immunocore Holdings stock is currently +27.04% from its 52-week low of $23.15, and -53.12% from its 52-week high of $62.74.
There are currently 50.07M IMCR shares outstanding. The market capitalization of IMCR is $1.47B. In the last 24 hours, 386,388 IMCR shares were traded.
How to Buy Immunocore Holdings Stock
Wondering how to invest in Immunocore Holdings stock? Here's how.
- Figure out where to buy Immunocore Holdings stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you figure out where to buy Immunocore Holdings stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Select your method of payment and add your information.
- Analyze Immunocore Holdings stock: The Immunocore Holdings ticker symbol is IMCR. Is Immunocore Holdings stock a good investment? Should you buy shares of IMCR? How do IMCR's underlying business fundamentals look? Do top analysts think Immunocore Holdings is a good buy? Why has IMCR's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if IMCR is a good stock to buy).
- Make your IMCR buy order: Decide if you will purchase IMCR shares at the current market price or use a limit order to purchase IMCR shares at a particular price.
- Keep an eye on your IMCR investment: Create a watchlist to keep track of your investment in Immunocore Holdings shares.
Step 1: Figure out where to buy Immunocore Holdings stock
You will need a brokerage account in order to access the NASDAQ market and buy IMCR stock.
Our favorite brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Technology to Financial Services, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal information so you are able to buy IMCR stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to open your new brokerage account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have finished signing up on one of the most highly reviewed stock market apps, your next step is to transfer the money for your investment:
Check out the walkthrough below if you need help depositing funds into your investment account.
Step 4: Analyze Immunocore Holdings stock
After you have decided on the best place to buy Immunocore Holdings stock, it's important to evaluate their stock before you invest, so you actually wrap your head around the risk as well as the opportunity.
Immunocore Holdings stock quick numbers
IMCR Due Diligence Score
WallStreetZen was built to help average investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on IMCR's stock page.
Is IMCR stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge IMCR's intrinsic value.
Using relative valuations measures:
- IMCR could be overvalued based on its P/B ratio of 4.08x, relative to Biotechnology industry P/B ratio of 4.04x
You can do additional valuation research on IMCR's stock here.
IMCR Financials at a glance
Signs that IMCR is financially healthy:
- There are more short-term assets than short-term liabilities on the IMCR balance sheet.
- Total IMCR debt is lower than 5 years ago, relative to shareholder equity.
- IMCR profit margin has gone up from -22.2% to -16.5% in the past year.
- There are more short-term assets than long-term liabilities on the IMCR balance sheet.
Signs that IMCR is not financially healthy:
- IMCR has a relatively high debt to equity ratio of 1.8.
- IMCR's operating cash flow of $26.06M allows it to safely service it's debt of $432.72M.
- IMCR earnings of -$34.09M is not sufficient to cover its interest payments.
Is it a good time to buy Immunocore Holdings stock, according to Wall Street analysts?
Out of 6 sell side analysts who track IMCR, the consensus analyst rating on Immunocore Holdings is a Hold
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Most Recent IMCR Analyst Ratings
David Dai, a bottom 5% analyst from UBS initiates coverage on IMCR with a strong sell rating and announces their IMCR price target of $24.00, on Oct 24, 2024.
You can dig deeper into what analysts are forecasting on the Immunocore Holdings stock forecast page.
Metrics for Advanced IMCR Traders
IMCR Earnings
Last year, IMCR revenue was $310.20M. Over the past 5 year, IMCR's revenue has gone up by 57.42% per year. This was faster than the Biotechnology industry average of 44.31%.
You can analyze IMCR's earnings and revenue performance here.
What are IMCR executives and large shareholders up to?
In the past 12 months, executives and large shareholders at IMCR have bought more shares than they have sold.
Baker Bros Advisors LP, Director of IMCR, was the latest IMCR insider to buy. They bought $1,787,791.62 worth of IMCR shares on Mar 17, 2025.
Research more about who owns IMCR stock here.
Can I get consistent income from IMCR stock?
No, Immunocore Holdings doesn't provide an income stream by paying out dividends.
IMCR Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your IMCR buy order
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount limit, use a limit order.
Press the Open Trade button and your broker will place the order.
If you need additional help with investing in stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your IMCR investment
Now that you own some IMCR stock, you'll want to stay up-to-date on your shares.
Start a watchlist to track the most important metrics related to your IMCR stock.
IMCR Feed
How to Buy Stock in Immunocore Holdings
To reiterate, here are the 6 steps you need to take to buy Immunocore Holdings stock right now:
- Figure out where to buy Immunocore Holdings stock
- Open a brokerage account
- Deposit funds into your investment account
- Analyze Immunocore Holdings stock
- Make your IMCR buy order
- Keep an eye on your IMCR investment
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to monitor your new investment in Immunocore Holdings, create a watchlist on WallStreetZen today.
Other Stock Buying Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.